Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8735556rdf:typepubmed:Citationlld:pubmed
pubmed-article:8735556lifeskim:mentionsumls-concept:C0020971lld:lifeskim
pubmed-article:8735556lifeskim:mentionsumls-concept:C0036125lld:lifeskim
pubmed-article:8735556lifeskim:mentionsumls-concept:C0042210lld:lifeskim
pubmed-article:8735556lifeskim:mentionsumls-concept:C1545588lld:lifeskim
pubmed-article:8735556lifeskim:mentionsumls-concept:C0439234lld:lifeskim
pubmed-article:8735556lifeskim:mentionsumls-concept:C0205473lld:lifeskim
pubmed-article:8735556lifeskim:mentionsumls-concept:C0148358lld:lifeskim
pubmed-article:8735556pubmed:issue5lld:pubmed
pubmed-article:8735556pubmed:dateCreated1996-10-17lld:pubmed
pubmed-article:8735556pubmed:abstractTextThe protective efficacy and immunogenicity of Vi capsular polysaccharide vaccine against typhoid fever was measured 3 years after its administration in a double-blind randomized trial. Vaccine efficacy was not significantly different during each year of the trial and was 55% (95% CI: 30-71%) over the 3 year period. In a case-control study at 3 years after vaccination, recipients of Vi had higher levels of Vi antibodies than controls, as measured by radio-immunoassay (GMT 1.28 vs 0.76 microgram ml-1, P = 0.0004) and by passive haemagglutination assay (GMT 10.46 vs 3.52, P = 0.0001). The serological correlate of protection has been estimated using the relative risks of typhoid fever in the 2 groups and the relative ratio of antibody levels. The estimated protective level is 1 microgram ml-1 suggesting that at a mean age of 9 years, 64% of vaccinates and 40% of controls had protective antibody against typhoid fever in this endemic area.lld:pubmed
pubmed-article:8735556pubmed:languageenglld:pubmed
pubmed-article:8735556pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8735556pubmed:citationSubsetIMlld:pubmed
pubmed-article:8735556pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8735556pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8735556pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8735556pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8735556pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8735556pubmed:statusMEDLINElld:pubmed
pubmed-article:8735556pubmed:monthAprlld:pubmed
pubmed-article:8735556pubmed:issn0264-410Xlld:pubmed
pubmed-article:8735556pubmed:authorpubmed-author:KoornhofH JHJlld:pubmed
pubmed-article:8735556pubmed:authorpubmed-author:RobbinsJ BJBlld:pubmed
pubmed-article:8735556pubmed:authorpubmed-author:KlugmanK PKPlld:pubmed
pubmed-article:8735556pubmed:authorpubmed-author:Le CamN NNNlld:pubmed
pubmed-article:8735556pubmed:issnTypePrintlld:pubmed
pubmed-article:8735556pubmed:volume14lld:pubmed
pubmed-article:8735556pubmed:ownerNLMlld:pubmed
pubmed-article:8735556pubmed:authorsCompleteYlld:pubmed
pubmed-article:8735556pubmed:pagination435-8lld:pubmed
pubmed-article:8735556pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:8735556pubmed:meshHeadingpubmed-meshheading:8735556-...lld:pubmed
pubmed-article:8735556pubmed:meshHeadingpubmed-meshheading:8735556-...lld:pubmed
pubmed-article:8735556pubmed:meshHeadingpubmed-meshheading:8735556-...lld:pubmed
pubmed-article:8735556pubmed:meshHeadingpubmed-meshheading:8735556-...lld:pubmed
pubmed-article:8735556pubmed:meshHeadingpubmed-meshheading:8735556-...lld:pubmed
pubmed-article:8735556pubmed:meshHeadingpubmed-meshheading:8735556-...lld:pubmed
pubmed-article:8735556pubmed:meshHeadingpubmed-meshheading:8735556-...lld:pubmed
pubmed-article:8735556pubmed:meshHeadingpubmed-meshheading:8735556-...lld:pubmed
pubmed-article:8735556pubmed:meshHeadingpubmed-meshheading:8735556-...lld:pubmed
pubmed-article:8735556pubmed:meshHeadingpubmed-meshheading:8735556-...lld:pubmed
pubmed-article:8735556pubmed:meshHeadingpubmed-meshheading:8735556-...lld:pubmed
pubmed-article:8735556pubmed:meshHeadingpubmed-meshheading:8735556-...lld:pubmed
pubmed-article:8735556pubmed:meshHeadingpubmed-meshheading:8735556-...lld:pubmed
pubmed-article:8735556pubmed:meshHeadingpubmed-meshheading:8735556-...lld:pubmed
pubmed-article:8735556pubmed:year1996lld:pubmed
pubmed-article:8735556pubmed:articleTitleImmunogenicity, efficacy and serological correlate of protection of Salmonella typhi Vi capsular polysaccharide vaccine three years after immunization.lld:pubmed
pubmed-article:8735556pubmed:affiliationDepartment of Medical Microbiology, School of Pathology, SAIMR/University of the Witwatersrand, Johannesburg, South Africa.lld:pubmed
pubmed-article:8735556pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8735556pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:8735556pubmed:publicationTypeRandomized Controlled Triallld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8735556lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8735556lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8735556lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8735556lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8735556lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8735556lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8735556lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8735556lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8735556lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8735556lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8735556lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:8735556lld:pubmed